Skip to main content

Susan Kay Murphy, PhD

Property title
Associate Professor in Obstetrics and Gynecology
Campus Mail: 226 B Wing LSRC, 450 Research Drive, Durham, NC 27708
Phone: (919) 681-3423
Email: susan.murphy@duke.edu

Ovarian and cervical cancer epigenetics, imprinted genes in ovarian and cervical cancers, identification of methylation biomarkers of disease, ovarian cancer stem cells, chemotherapeutic response in ovarian cancer, tumor dormancy, the influence of the in utero environment on DNA methylation and risk of disease.

Education and Training

  • Ph.D., Wake Forest University, 1998
  • B.A., University of North Carolina at Charlotte, 1992

Selected Grants and Awards

Publications

Vidal, AC, Smith, JS, Valea, F, Bentley, R, Gradison, M, Yarnall, KSH, Ford, A, Overcash, F, Grant, K, Murphy, SK, and Hoyo, C. "HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA." Cancer causes & control : CCC 25, no. 8 (August 2014): 1055-1062.

Full Text

Murphy, SK. "Obesity: Paternal obesity--a risk factor for autism?." Nature reviews. Endocrinology 10, no. 7 (July 2014): 389-390.

Full Text

Smeester, L, Yosim, AE, Nye, MD, Hoyo, C, Murphy, SK, and Fry, RC. "Imprinted genes and the environment: links to the toxic metals arsenic, cadmium, lead and mercury." Genes 5, no. 2 (June 11, 2014): 477-496.

Full Text

Soubry, A, Hoyo, C, Jirtle, RL, and Murphy, SK. "A paternal environmental legacy: Evidence for epigenetic inheritance through the male germ line." BioEssays 36, no. 4 (April 1, 2014): 359-371.

Full Text

Soubry, A, Hoyo, C, Jirtle, RL, and Murphy, SK. "A paternal environmental legacy: evidence for epigenetic inheritance through the male germ line." BioEssays : news and reviews in molecular, cellular and developmental biology 36, no. 4 (April 2014): 359-371.

Full Text

Vidal, AC, Henry, NM, Murphy, SK, Oneko, O, Nye, M, Bartlett, JA, Overcash, F, Huang, Z, Wang, F, Mlay, P, Obure, J, Smith, J, Vasquez, B, Swai, B, Hernandez, B, and Hoyo, C. "PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer." Clinical and Translational Oncology 16, no. 3 (March 1, 2014): 266-272.

Full Text

Vidal, AC, Henry, NM, Murphy, SK, Oneko, O, Nye, M, Bartlett, JA, Overcash, F, Huang, Z, Wang, F, Mlay, P, Obure, J, Smith, J, Vasquez, B, Swai, B, Hernandez, B, and Hoyo, C. "PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer." Clin Transl Oncol 16, no. 3 (March 2014): 266-272.

Full Text

Secord, AA, Teoh, D, Jia, J, Nixon, AB, Grace, L, Adams, DJ, and Murphy, SK. "Dasatinib (BMS-35482) interacts synergistically with docetaxel, gemcitabine, topotecan, and doxorubicin in ovarian cancer cells with high SRC pathway activation and protein expression." Int J Gynecol Cancer 24, no. 2 (February 2014): 218-225.

Full Text

Moylan, CA, Pang, H, Dellinger, A, Suzuki, A, Garrett, ME, Guy, CD, Murphy, SK, Ashley-Koch, AE, Choi, SS, Michelotti, GA, Hampton, DD, Chen, Y, Tillmann, HL, Hauser, MA, Abdelmalek, MF, and Diehl, AM. "Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease." Hepatology 59, no. 2 (February 2014): 471-482.

Full Text

Davidson, BA, Rubatt, JM, Corcoran, DL, Teoh, DK, Bernardini, MQ, Grace, LA, Soper, WJ, Berchuck, A, Siamakpour-Reihani, S, Chen, W, Owzar, K, Murphy, SK, and Secord, AA. "Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines." Frontiers in Oncology 4 (January 2014): 163-.

Full Text

Pages